FDA Strengthens Warning Label On Roche HIV Drug
The U.S. Food and Drug Administration has beefed up the warning label for Roche Holding AG's HIV treatment Invirase, cautioning patients and doctors that when used in combination with Abbott Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article